Security key
22978P106
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 43,411,663
- Total 13F shares
- 16,042,165
- Share change
- +3,012,385
- Total reported value
- $393,156,090
- Put/Call ratio
- 133%
- Price per share
- $24.51
- Number of holders
- 99
- Value change
- +$84,955,728
- Number of buys
- 71
- Number of sells
- 23
Report period
Q2 2020
Institutions
99
Top holders
10
CUE full security history
Newer quarter: Q3 2020
Previous quarter: Q1 2020
Cue Biopharma, Inc. SEC filings
Cue Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22978P106
Recent filing periods:
Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC |
13F
|
Company |
5.8%
|
2,503,840
|
$35,529,000 | — | 31 Mar 2020 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
4.3%
|
1,870,000
|
$26,535,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.1%
|
1,329,428
|
$18,865,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.1%
|
927,287
|
$13,159,000 | — | 31 Mar 2020 | |
| Slate Path Capital LP |
13F
|
Company |
2%
|
870,694
|
$12,355,000 | — | 31 Mar 2020 | |
| Corriente Advisors, LLC |
13F
|
Company |
1.9%
|
820,000
|
$11,636,000 | — | 31 Mar 2020 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
1.4%
|
601,398
|
$8,534,000 | — | 31 Mar 2020 | |
| Prosight Management, LP |
13F
|
Company |
1.3%
|
552,060
|
$7,834,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.86%
|
371,783
|
$5,276,000 | — | 31 Mar 2020 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.74%
|
320,000
|
$4,541,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
308,587
|
$4,378,000 | — | 31 Mar 2020 | |
| Crestwood Advisors Group, LLC |
13F
|
Company |
0.62%
|
270,000
|
$3,831,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.54%
|
236,474
|
$3,355,000 | — | 31 Mar 2020 | |
| PRECEPT MANAGEMENT LLC |
13F
|
Company |
0.48%
|
210,000
|
$2,980,000 | — | 31 Mar 2020 | |
| Bleichroeder LP |
13F
|
Company |
0.38%
|
165,000
|
$2,341,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.36%
|
156,421
|
$2,219,000 | — | 31 Mar 2020 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.29%
|
125,000
|
$1,774,000 | — | 31 Mar 2020 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.21%
|
93,148
|
$1,334,000 | — | 31 Mar 2020 | |
| Voss Capital, LP |
13F
|
Company |
0.2%
|
88,670
|
$749,000 | — | 31 Mar 2020 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.2%
|
86,986
|
$1,234,000 | — | 31 Mar 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.2%
|
86,559
|
$1,228,000 | — | 31 Mar 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.19%
|
80,393
|
$1,141,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.17%
|
74,418
|
$1,056,000 | — | 31 Mar 2020 | |
| Sigma Planning Corp |
13F
|
Company |
0.15%
|
66,245
|
$940,000 | — | 31 Mar 2020 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.13%
|
55,855
|
$792,000 | — | 31 Mar 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.12%
|
50,387
|
$715,000 | — | 31 Mar 2020 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.11%
|
49,653
|
$701,000 | — | 31 Mar 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.1%
|
43,944
|
$623,000 | — | 31 Mar 2020 | |
| PA Capital LLC |
13F
|
Company |
0.09%
|
40,706
|
$578,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.09%
|
39,202
|
$556,000 | — | 31 Mar 2020 | |
| Rock Creek Group LLC |
13F
|
Company |
0.09%
|
38,670
|
$549,000 | — | 31 Mar 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.09%
|
37,862
|
$537,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0.07%
|
30,955
|
$439,000 | — | 31 Mar 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.07%
|
30,904
|
$439,000 | — | 31 Mar 2020 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.07%
|
30,800
|
$437,000 | — | 31 Mar 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.07%
|
30,049
|
$426,000 | — | 31 Mar 2020 | |
| STRS OHIO |
13F
|
Company |
0.06%
|
28,200
|
$400,000 | — | 31 Mar 2020 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.06%
|
26,371
|
$362,000 | — | 31 Mar 2020 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.06%
|
24,631
|
$350,000 | — | 31 Mar 2020 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.05%
|
21,918
|
$311,000 | — | 31 Mar 2020 | |
| WESTWOOD HOLDINGS GROUP INC |
13F
|
Company |
0.05%
|
20,700
|
$294,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
19,023
|
$270,000 | — | 31 Mar 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.04%
|
18,800
|
$267,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
18,084
|
$257,000 | — | 31 Mar 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
14,000
|
$199,000 | — | 31 Mar 2020 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.03%
|
13,476
|
$191,000 | — | 31 Mar 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.03%
|
13,200
|
$187,000 | — | 31 Mar 2020 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.03%
|
12,370
|
$176,000 | — | 31 Mar 2020 | |
| Trexquant Investment LP |
13F
|
Company |
0.03%
|
12,285
|
$174,000 | — | 31 Mar 2020 | |
| DOHENY ASSET MANAGEMENT /CA |
13F
|
Company |
0.03%
|
12,160
|
$193,000 | — | 31 Mar 2020 |
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2020
As of 30 Jun 2020,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,042,165 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, BlackRock Inc., Avoro Capital Advisors LLC, VANGUARD GROUP INC, STATE STREET CORP, Slate Path Capital LP, Corriente Advisors, LLC, Woodline Partners LP, GEODE CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP.
This page lists
99
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
72
Q2 2020 holders
99
Holder diff
27
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.